CTSH Stock Chart & Stats
$1065.00
$0.00(0.00%)
At close: 4:00 PM EDT
$1065.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$2.71 - $1,531.00
Previous CloseN/A
Volume0.00
Average Volume (3M)28.00
Market Cap
$557.85B
Enterprise Value$19.09B
Total Cash (Recent Filing)$1.55B
Total Debt (Recent Filing)$2.13B
Price to Earnings (P/E)14.2
Beta0.56
Next Earnings
Feb 10, 2027EPS Estimate
28.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.49
Shares Outstanding450,444,200
10 Day Avg. Volume42
30 Day Avg. Volume28
Financial Highlights & Ratios
PEG Ratio20.57
Price to Book (P/B)2.66
Price to Sales (P/S)1.89
P/FCF Ratio15.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,321.94Price Target Upside24.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)107.7
Revenue Forecast (FY)$414.90B
Bulls Say, Bears Say
Bulls Say
AI Capabilities And AdoptionBroad AI deployment across delivery and a substantial engagement base strengthen Cognizant’s ability to capture enterprise modernization demand. Its trained workforce, expanding certifications, and AI platforms can improve productivity while creating differentiated, repeatable services for clients over the next several quarters.
Bookings And Financial-services MomentumBookings above revenue and a 1.3x book-to-bill indicate continued demand coverage, while double-digit Financial Services growth provides a strong vertical engine. The higher share of new and expansion bookings supports future revenue visibility and broadens the foundation for sustained growth.
Low Leverage And Solid Cash GenerationVery low leverage gives Cognizant financial flexibility to invest in AI, pursue targeted acquisitions, and return capital without relying heavily on debt. Meaningfully positive operating and free cash flow also support earnings quality and provide internal funding for strategic priorities.
Bears Say
Persistent Margin CompressionAlthough profitability remains solid, lower margins than in earlier periods suggest ongoing pricing, mix, or cost pressure within the services model. If this persists, revenue growth may translate less effectively into earnings and could constrain investment capacity or limit operating leverage.
Reduced Growth Outlook And Discretionary PressureThe lower outlook signals that client budget caution is affecting near-term demand, particularly where spending is discretionary. Health care and consumer-facing exposure could make growth uneven over the next several quarters, reducing confidence in acceleration despite Cognizant’s strategic AI opportunities.
Uneven Cash Conversion And Working-capital PressurePositive cash generation remains substantial, but declining free cash flow and recurring operating-cash-flow coverage below net income indicate weaker conversion than earnings alone suggest. Higher receivables can absorb liquidity and make funding for investment, acquisitions, or shareholder returns less predictable.
CTSH FAQ
What was Cognizant Technology Solutions’s price range in the past 12 months?
Cognizant Technology Solutions lowest stock price was $2.71 and its highest was $1531.00 in the past 12 months.
What is Cognizant Technology Solutions’s market cap?
Cognizant Technology Solutions’s market cap is $557.85B.
When is Cognizant Technology Solutions’s upcoming earnings report date?
Cognizant Technology Solutions’s upcoming earnings report date is Feb 10, 2027 which is in 104 days.
How were Cognizant Technology Solutions’s earnings last quarter?
Cognizant Technology Solutions released its earnings results on Oct 29, 2026. The company reported $27.807 earnings per share for the quarter, beating the consensus estimate of $27.322 by $0.485.
Is Cognizant Technology Solutions overvalued?
According to Wall Street analysts Cognizant Technology Solutions’s price is currently Undervalued.
Does Cognizant Technology Solutions pay dividends?
Cognizant Technology Solutions does not currently pay dividends.
What is Cognizant Technology Solutions’s EPS estimate?
Cognizant Technology Solutions’s EPS estimate is 28.27.
How many shares outstanding does Cognizant Technology Solutions have?
Cognizant Technology Solutions has 450,444,200 shares outstanding.
What happened to Cognizant Technology Solutions’s price movement after its last earnings report?
Cognizant Technology Solutions reported an EPS of $27.807 in its last earnings report, beating expectations of $27.322. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cognizant Technology Solutions?
Currently, no hedge funds are holding shares in MX:CTSH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cognizant Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1,321.94 (24.13% Upside)
$1,321.94 (24.13% Upside)
Blogger Sentiment
Bullish
MX:CTSH Sentiment 89%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.05%
12-Months-Change
Fundamentals
Return on Equity
14.94%
Trailing 12-Months
Asset Growth
3.28%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cognizant Technology Solutions
Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing processes. Its clientele in this domain spans healthcare providers, payers, and life sciences organizations, encompassing pharmaceutical, biotechnology, and medical device firms. In the Products and Resources segment, the company develops solutions tailored for manufacturers, retailers, and entities within the travel and hospitality sectors, alongside those engaged in logistics, energy, and utility services. Within the Communications, Media and Technology division, Cognizant supports businesses in creating digital content, crafting personalized user experiences, and expediting digital engineering efforts. This includes serving information, media, entertainment, communications, and technology enterprises. Established in 1994, the company maintains its primary corporate office in Teaneck, New Jersey.
CTSH Company Deck
CTSH Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was broadly positive. Cognizant delivered solid revenue growth, its highest adjusted operating margin in four years, strong Financial Services momentum, improved bookings mix, rising AI adoption and robust cash generation. Management also highlighted significant investments in AI talent, platforms, partnerships and growth priorities. These strengths were partly offset by reduced full-year guidance, softer fourth-quarter expectations, discretionary spending pressure in health care and consumer-facing sectors, industry-specific challenges, and higher furlough and restructuring impacts.View all MX:CTSH earnings summariesCTSH Revenue Breakdown
30.06% Health Sciences
29.15% Financial Services
24.23% Products and Resources
16.56% Communications, Media and Technology

CTSH Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$1,321.94
▲(24.13% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month








